NCT03542669 Study of 6b11-OCIK Injection Treatment in Patients With Recurrent Drug-resistant Ovarian Cancer Status UNKNOWN Phase PHASE1
NCT02575807 Safety and Efficacy of CRS-207 With Epacadostat in Platinum Resistant Ovarian, Fallopian or Peritoneal Cancer Status TERMINATED Phase PHASE1/PHASE2